Delivery Order SPE2DB24D1021-SPE2DB25FEXDJ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,445.44 to AmerisourceBergen Drug Corp for the supply of Botox 100 unit vials. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of June 24, 2025. The contract is being performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $3,011.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox, with an ultimate completion date of August 19, 2025. The contract, which was competitively awarded with no set-aside designation, is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a $2,624.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Botox Cosmetic 100 unit vials, with an ultimate completion date of July 11, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,722.72 to AmerisourceBergen Drug Corp for BOTOX 100 Unit Vials, with an ultimate completion date of August 20, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor will fulfill this order from its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $1,722.72. This firm fixed price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $4,818.00 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX on August 6, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $11,642.60 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of 200 unit BOTOX vials to a location in Conshohocken, Pennsylvania by March 19, 2024. This award is part of Amerisourcebergen Drug Corp's role as the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $3,011.25 to supply 200-unit vials of BOTOX. The contract was competitively awarded without a set-aside designation and is structured as a firm fixed price delivery order with an ultimate completion date of August 26, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of BOTOX 200 unit vials. The $13,971.12 firm-fixed-price contract has a completion date of September 12, 2024 and was awarded on August 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical that enables DLA to efficiently procure a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide BOTOX 200 unit vials. The $3,492.78 order has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is a subsidiary of the larger Amerisourcebergen Corporation and serves as a prime contractor to DLA, providing a range of pharmaceutical products and medical supplies in support of military treatment...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEXDJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Botox 100 unit vials under a firm fixed-price contract valued at $4,306.80, with an ultimate completion date of June 20, 2025. This non-set-aside, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's substantial DLA Troop Support Medical IDC provides comprehensive global pharmaceutical support across multiple therapeutic domains, enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. This delivery order for Botox reflects the company's established role in fulfilling federal medical supply requirements through its extensive portfolio of pharmaceutical products and its demonstrated capability to meet competitive federal procurement standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 5/29/25 |